OGN R&D Expenses

Organon & Co. Common Stock · R&D Expenses

OGN logo

OGN R&D Expenses

Latest reported$358.00M
OGN TTM R&D Expenses ($210.00M → $358.00M)
High-resolution chart · PNG

OGN r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Organon & Co. Common Stock R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
358,000,000
363,000,000
366,000,000
405,000,000
432,000,000
453,000,000
469,000,000
473,000,000
499,000,000
511,000,000
528,000,000
536,000,000
526,000,000
504,000,000
471,000,000
439,000,000
423,000,000
393,000,000
364,000,000
314,000,000
257,000,000
232,000,000
210,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.